Art Therapy for Chronic Pain and Opioid Use Disorder

N/A

Recruiting

Led By Jenny Seham, PhD

Research Sponsored by Montefiore Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Are aged 18 or older

Be older than 18 years old

Must not have

Are not fluent in either English or Spanish

Timeline

Screening 3 weeks

Treatment Varies

Follow Up before and after a microintervention within a 24 hour period, up to 4 months

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to see if individuals with chronic pain and opioid misuse will engage in self-directed art making. It also looks at whether this art practice can help reduce pain, lessen depression and anxiety, and

Who is the study for?

This trial is for individuals with chronic pain and opioid use disorder or opioid misuse. It's designed to see if they will engage in self-driven artmaking on their own as a potential therapeutic activity.

What is being tested?

The study tests the acceptability of self-directed repetitive artmaking practice. It aims to determine if this creative process can reduce pain, alleviate depression and anxiety, and enhance social connectedness among participants.

What are the potential side effects?

Since the intervention involves artmaking, traditional medical side effects are not applicable. However, participants may experience emotional or psychological responses related to engaging in artistic expression.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am not fluent in English or Spanish.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ before and after a microintervention within a 24 hour period, up to 4 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~before and after a microintervention within a 24 hour period, up to 4 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and before and after a microintervention within a 24 hour period, up to 4 months for reporting.